Biologics to the fore in new AS guidelines

American College of Rheumatology guidelines for the treatment of ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) have been updated with new information, including the management of biologics and their biosimilars. The update was based on a systematic literature review for 20 clinical questions on drug treatment addressed in the previous 2015 guidelines along with ...

Already a member?

Login to keep reading.

© 2021 the limbic